Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 27.07.2026 1 Am Heart J 1 Am J Epidemiol 1 Am J Hypertens 1 Am J Kidney Dis 1 Am J Ophthalmol 2 Angiology 2 Ann Intern Med 1 BMJ 2 Br J Ophthalmol 1 Circulation 5 Diabet Med 7 Diabetes 12 Diabetes Care 15 Diabetes Obes Metab 2 Diabetologia 2 Invest Ophthalmol Vis Sci 1 J Am Soc Nephrol 1 J Clin Endocrinol Metab 4 JAMA 3 Kidney Int 4 Metabolism 1 Nature 1 Ophthalmology 8 PLoS One 3 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. SANTO K, Martins E, Silva GS, Guimaraes PO, et al
   Intensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes: Rationale, Design and Baseline Characteristics of the OPTIMAL-DIABETES Randomized Trial.
   Am Heart J. 2026 Jul 24:107545. doi: 10.1016/j.ahj.2026.107545.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. WANG Y, Guo D, Xia Y, Shi Z, et al
   Effects of the integrated care on healthcare utilization and costs among patients with diabetes and depression: a cluster randomized controlled trial.
   Am J Epidemiol. 2026 Jul 20:kwag175. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

3. LIU H, Wu S, Liu T
   Response to "Competing Risk of Death and the Hypertension-Atrial Fibrillation Association in Diabetes".
   Am J Hypertens. 2026 Jul 22:hpag092. doi: 10.1093.
   PubMed        
   
   

   
   Am J Kidney Dis

4. PALMER BF, Clegg DJ
   Pathophysiology of Ketoacidosis: Core Curriculum 2026.
   Am J Kidney Dis. 2026;88:301-314.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

5. ALHELALY M, Abbasgholizadeh R, Chung YC, Habibi A, et al
   Comparison of Retinal Nonperfusion in Diabetic Macular Edema Treated with Brolucizumab Versus Aflibercept: A KINGFISHER Trial Analysis.
   Am J Ophthalmol. 2026 Jul 23:S0002-9394(26)00419.
   PubMed         Abstract available
   
   

   
   Angiology

6. ZHENG Z, He J, Song Y, Shi S, et al
   Triglyceride-Glucose Index Mediated by Metabolic Burden Predicts Cardiovascular Events in Patients With Complex Coronary Lesions: A Prospective Cohort Study.
   Angiology. 2025 Nov 18:33197251390139. doi: 10.1177/00033197251390139.
   PubMed         Abstract available
   
   
7. YIN Y, Yang T, Liu Y, Li Y, et al
   Association Between Hepatic Steatosis With Significant Fibrosis and CAD Severity in Different Glucose Metabolic States: A CSCD-TCM (plus) Study.
   Angiology. 2026;77:1016-1026.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

8. CROWLEY MJ, Lewinski AA, Yang Q, Hatch D, et al
   Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care : A Pragmatic, Randomized, Effectiveness-Implementation Trial.
   Ann Intern Med. 2026;179:968-979.
   PubMed         Abstract available
   
   
9. BROWN JP, Huybrechts KF, Straub L, Patorno E, et al
   Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes : A Target Trial Emulation Study Using Claims Information.
   Ann Intern Med. 2026;179:929-937.
   PubMed         Abstract available
   
   

   
   BMJ

10. TANG H, Zhang B, Lu Y, Zhang D, et al
    Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation.
    BMJ. 2026;394:e100077.
    PubMed         Abstract available
    
    

    
    Br J Ophthalmol

11. GUAN Z, Li Y, Li Y, Qian Z, et al
    Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes.
    Br J Ophthalmol. 2026 Jul 20:bjo-2025-328581. doi: 10.1136/bjo-2025-328581.
    PubMed         Abstract available
    
    
12. SANTOS AR, Almeida A, Pinto I, Rocha AC, et al
    Cross-device consistency in diabetic retinopathy grading: a comparative analysis of widefield versus standard 30-35 degrees - the ClarusDR study.
    Br J Ophthalmol. 2026 Jul 23:bjo-2025-329382. doi: 10.1136/bjo-2025-329382.
    PubMed         Abstract available
    
    

    
    Circulation

13. NAU C, Wu JHY, Han B, Habib M, et al
    Effects of a "Food Is Medicine" Intervention on Glucose Control Among Medicaid-Insured Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Circulation. 2026 Jul 21. doi: 10.1161/CIRCULATIONAHA.125.077982.
    PubMed         Abstract available
    
    

    
    Diabet Med

14. COOPER L, Porter I, Meek C, Griffin SJ, et al
    Sex-specific differences in the prevalence of intermediate hyperglycaemia states: A systematic review and meta-analysis.
    Diabet Med. 2026;43:e70293.
    PubMed         Abstract available
    
    
15. KARIPIDOU M, Liatis S, Kyrkili A, Skoufi A, et al
    Determinants of health-related quality of life in adults with type 1 diabetes: The predominant role of sleep among lifestyle parameters.
    Diabet Med. 2026 Jul 19:e70432. doi: 10.1111/dme.70432.
    PubMed         Abstract available
    
    
16. DE TERWANGNE C, Henrard S, Marien S, Steinman MA, et al
    Diabetes overtreatment and flags for deprescribing glucose-lowering treatment in geriatric inpatients with type 2 diabetes: Prognostic insights from a longitudinal cohort.
    Diabet Med. 2026 Jul 22:e70435. doi: 10.1111/dme.70435.
    PubMed         Abstract available
    
    
17. FERNANDO M, Pena AS, King A, Oxlad M, et al
    It's a game changer in terms of diabetic management': A qualitative study of adolescents' and parents' experiences of a 6-month trial of continuous glucose monitoring in type 2 diabetes.
    Diabet Med. 2026 Jul 22:e70430. doi: 10.1111/dme.70430.
    PubMed         Abstract available
    
    
18. PIRAS G, Bassi M, Milioto A, Calevo MG, et al
    Glycaemia risk index and continuous glucose monitoring metrics across menstrual cycle phases in women with type 1 diabetes using automated insulin delivery.
    Diabet Med. 2026 Jul 22:e70436. doi: 10.1111/dme.70436.
    PubMed        
    
    

    
    Diabetes

19. KUPPAN P, Castro C, Paramor J, Waduthanthri KD, et al
    Nanofibrous Bioabsorbable Functionalized Scaffolds Augment Subcutaneous Islet Engraftment and Function in Mice.
    Diabetes. 2026;75:1424-1436.
    PubMed         Abstract available
    
    
20. TAN X, Guan L, Li W, Zhang MY, et al
    VDAC1 O-GlcNAcylation Promotes mtDNA Release and Activates ZBP1-Dependent Neuroinflammation in Diabetic Retinopathy.
    Diabetes. 2026 Jul 20:db260151. doi: 10.2337/db26-0151.
    PubMed         Abstract available
    
    
21. PAGE B
    Diabetes Spotlight: Erin Mulvilhill, PhD-Modeling Diabetes and Cardiovascular Disease for Patient-Driven Outcomes.
    Diabetes. 2026;75:1339.
    PubMed        
    
    
22. 
    Statement of Retraction. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I. Diabetes 2009;58:1893-1901. DOI: 10.2337
    Diabetes. 2026;75:1494.
    PubMed        
    
    
23. 
    Statement of Retraction. Yunzhou Dong, Miao Zhang, Shuangxi Wang, Bin Liang, Zhengxing Zhao, Chao Liu, Mingyuan Wu, Hyoung Chul Choi, Timothy J. Lyons, and Ming-Hui Zou. Activation of AMP-Activated Protein Kinase Inhibits Oxidized LDL-Triggered Endopl
    Diabetes. 2026;75:1493.
    PubMed        
    
    
24. AI S, Ding Y, Zhang C, Li Z, et al
    FcRn Upregulation Exacerbates Podocyte Injury via Insulin Resistance-Induced Autophagy Disorder in Diabetic Kidney Disease.
    Diabetes. 2026 Jul 22:db260008. doi: 10.2337/db26-0008.
    PubMed         Abstract available
    
    
25. MOUSTAFA M, Guirguis Y, Humble J, Grace M, et al
    Deletion of 12/15-Lipoxygenase Preserves Retinal Thickness and Function and Selectively Restores Dysregulated miRNAs in Experimental Diabetes Mice.
    Diabetes. 2026 Jul 22:db260179. doi: 10.2337/db26-0179.
    PubMed         Abstract available
    
    

    
    Diabetes Care

26. STROHHOFER C, Eberhard K, Obermayer-Pietsch B, Stadler D, et al
    Enzymatic 2-Hydroxybutyrate Measurement for Dysglycemia Screening Beyond Conventional Fasting Measures.
    Diabetes Care. 2026;49:1374-1379.
    PubMed         Abstract available
    
    
27. MELLOR JC, Blackbourn LAK, McGurnaghan SJ, McKeigue PM, et al
    Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort.
    Diabetes Care. 2026;49:1348-1356.
    PubMed         Abstract available
    
    
28. XU Q, Xu F
    Comment on Nagai et al. The Association Between Race/Ethnicity and Risk of Type 2 Diabetes in Women Varies by BMI: A Pooled Analysis of Individual Data From 15 Cohort Studies.
    Diabetes Care. 2026;49:e144.
    PubMed        
    
    
29. NARAYAN KMV
    Global Diabetes: Rapidly Changing Landscape and a Rising Tide of Opportunities: The 2025 Distinguished International Service in the Cause of Diabetes Award Lecture.
    Diabetes Care. 2026;49:1297-1307.
    PubMed         Abstract available
    
    
30. JACOBSEN LM, Campbell-Thompson M, Wasserfall C, Atkinson MA, et al
    Identifying the Right Diagnosis of Diabetes in Death: Unlocking A Key to Understanding Type 1 Diabetes Pathogenesis.
    Diabetes Care. 2026 Jul 22:dci260020. doi: 10.2337/dci26-0020.
    PubMed         Abstract available
    
    
31. HOSSMANN S, Friedman M, Lizoain A, Caduff M, et al
    Effects of Menstrual Cycle on Insulin Sensitivity in Type 1 Diabetes: An Observational Study of Individuals Using an Automated Insulin Delivery System.
    Diabetes Care. 2026 Jul 22:dc260692. doi: 10.2337/dc26-0692.
    PubMed         Abstract available
    
    
32. FAGHERAZZI G, Cosson E, Mathieu C, Scibilia R, et al
    Diabetes Care in 2050: A Human-Centered Road Map From Time in Range to Time in Happiness.
    Diabetes Care. 2026 Jul 21:dci260059. doi: 10.2337/dci26-0059.
    PubMed         Abstract available
    
    
33. CORAL L, Franks PW
    Data-Driven Subclassification of Prediabetes and Diabetes in South Asian Adults From India.
    Diabetes Care. 2026;49:1318-1320.
    PubMed        
    
    
34. CHEN S, Zhang J
    Comment on Dumortier et al. Effects of Sodium-Glucose Cotransporter 2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer.
    Diabetes Care. 2026;49:e141.
    PubMed        
    
    
35. DI MOLFETTA S, Di Gioia L, Caruso I, Laviola L, et al
    Comment on Hespanhol et al. Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
    Diabetes Care. 2026;49:e147-e148.
    PubMed        
    
    
36. BOUILLET B, Aho Glele S
    Response to Comments on Dumortier et al. Effects of Sodium-Glucose Cotransporter 2 Inhibitor Use on Mortality, Amputation, and Healing in Patients With Diabetic Foot Ulcer.
    Diabetes Care. 2026;49:e142-e143.
    PubMed        
    
    
37. NAGAI K, Chung HF, Hayashi K, Mishra GD, et al
    Response to Comment on Nagai et al. The Association Between Race/Ethnicity and Risk of Type 2 Diabetes in Women Varies by BMI: A Pooled Analysis of Individual Data From 15 Cohort Studies.
    Diabetes Care. 2026;49:e145-e146.
    PubMed        
    
    

    
    Diabetes Obes Metab

38. SU H, Ni J, Cai J, Zhu W, et al
    Association Between Time in Range and Advanced Cardiovascular-Kidney-Metabolic Syndrome in Older Adults With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jul 22. doi: 10.1111/dom.71143.
    PubMed         Abstract available
    
    
39. ZANFARDINO A, Iafusco D, Ippolito G, Del Giudice EM, et al
    Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study.
    Diabetes Obes Metab. 2026 Jul 23. doi: 10.1111/dom.71101.
    PubMed         Abstract available
    
    
40. YE C, Zhang Z, Ding Y, Yu Y, et al
    Large-Scale Plasma Proteomics Enhances Prediction of Liver-Related Events Among Individuals With Prediabetes and Type 2 Diabetes: A Prospective Cohort Study in the UK Biobank.
    Diabetes Obes Metab. 2026 Jul 23. doi: 10.1111/dom.71113.
    PubMed         Abstract available
    
    
41. RUMANES A, Linssen GCM, van Netten JJ, van Gemert-Pijnen JEWC, et al
    Diabetic Foot Ulcers Are Clinical Marker of Disease Burden in People With Diabetes and Heart Failure.
    Diabetes Obes Metab. 2026 Jul 21. doi: 10.1111/dom.71121.
    PubMed         Abstract available
    
    
42. OKA S, Takemura K, Takefuji Y
    Feature Importance Bias and Competing Risks: Methodological Concerns in Ensemble Models for Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Jul 21. doi: 10.1111/dom.71140.
    PubMed        
    
    
43. ECHOUFFO-TCHEUGUI JB, McCormack D, Ke C, Retnakaran R, et al
    Antecedent of Pregnancy-Related Cardiometabolic Complication and Risk of Cardiovascular Disease Among Women With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jul 21. doi: 10.1111/dom.71119.
    PubMed         Abstract available
    
    
44. ERVITI J, van Bruggen FH, Saiz LC, Wright JM, et al
    Mortality in FOURIER Participants With Diabetes: A Regulatory-Data Reanalysis of Evolocumab Outcomes.
    Diabetes Obes Metab. 2026 Jul 20. doi: 10.1111/dom.71108.
    PubMed        
    
    
45. MCNALLY E, Goodman I, Morris R, Maliekkal J, et al
    Looking Beyond Glycaemic Control: Real-World 12-Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Jul 20. doi: 10.1111/dom.71129.
    PubMed         Abstract available
    
    
46. ONG YL, Liew ZH, Lim GH, Tan NC, et al
    A Real-World Cohort Study on the Association of the Use of Sodium-Glucose Cotransporter-2 Inhibitor With the Incidence of Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus Without CKD Using the SingHealth Diabetes Registry.
    Diabetes Obes Metab. 2026 Jul 20. doi: 10.1111/dom.71137.
    PubMed         Abstract available
    
    
47. SHIMODA M, Osonoi T, Iwamoto M, Kaneto H, et al
    Durability and Safety of Imeglimin as an Add-On to DPP-4 Inhibitors in Japanese Type 2 Diabetes: The 104-Week FAMILIAR Trial.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71079.
    PubMed         Abstract available
    
    
48. ZHANG S, Gu Y, Cheng Y, Hu Y, et al
    Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli-D Study.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71057.
    PubMed         Abstract available
    
    
49. TIMMONS JG, Ghanim H, Boyle JG, Greenlaw N, et al
    Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71076.
    PubMed         Abstract available
    
    
50. DARMON P, Boureau AS, Bauduceau B, Charbit J, et al
    Continuous Glucose Monitoring in Older-Old With Type 2 Diabetes Mellitus: A Narrative Review of Evidence and Recommendations.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71118.
    PubMed         Abstract available
    
    
51. XU W, Di L, Wang X, Miao Q, et al
    Metformin Ameliorates Diabetes-Associated Cognitive Dysfunction via p53/Parkin-Mediated Mitophagy.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71093.
    PubMed         Abstract available
    
    
52. JANCEV M, Eliasson B, Biessels GJ, DeVries JH, et al
    Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register-Based Cohort Study.
    Diabetes Obes Metab. 2026 Jul 19. doi: 10.1111/dom.71123.
    PubMed         Abstract available
    
    

    
    Diabetologia

53. HASHIM D, Jorgensen JA, van de Weijer T, Blondin DP, et al
    Acute mild cold exposure with shivering reduces 24 h glucose levels in individuals with type 2 diabetes but not prediabetes.
    Diabetologia. 2026 Jul 20. doi: 10.1007/s00125-026-06809.
    PubMed         Abstract available
    
    
54. LEFERE S, Putri RR, Danielsson P, Casswall T, et al
    pFIB scores for paediatric MASLD fibrosis are associated with risk of youth-onset type 2 diabetes in children with obesity.
    Diabetologia. 2026 Jul 22. doi: 10.1007/s00125-026-06804.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

55. CHLAN E, Li C, Bales KL, Wood LB, et al
    L-DOPA Promotes Post-Treatment Neurovascular and Synaptic Homeostasis in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:42.
    PubMed         Abstract available
    
    
56. ZAIDI SAH, Lemtalsi T, Xu Z, Yamamoto M, et al
    Novel Role of AcylCoA: Cholesterol Acyltransferase 1/Sterol O-Acyltransferase 1 (ACAT1/SOAT1) in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:52.
    PubMed         Abstract available
    
    

    
    J Am Soc Nephrol

57. LI J, Gonzalez Villalobos RA, Rutkoski TJ, Farrington KP, et al
    VEGFR1-Blocking Antibody Improves Endothelial Structure, Kidney Function, and GFR in Diabetic Mice.
    J Am Soc Nephrol. 2026 Jul 20. doi: 10.1681/ASN.0000001176.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

58. 
    Correction to: Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials.
    J Clin Endocrinol Metab. 2026 Jul 22:dgag275. doi: 10.1210.
    PubMed        
    
    

    
    JAMA

59. MARSTON NA, Bohula EA, Sabatine MS
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis-Reply.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10555.
    PubMed        
    
    
60. GOOD CB, Do S, Peasah S
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10552.
    PubMed        
    
    
61. HUANG J
    Evolocumab to Reduce Cardiovascular Events in Patients With Diabetes Without Known Significant Atherosclerosis.
    JAMA. 2026 Jul 23. doi: 10.1001/jama.2026.10549.
    PubMed        
    
    
62. ANDERER S
    GLP-1 Medications May Improve Health in People With PAD and Diabetes.
    JAMA. 2026 Jul 24. doi: 10.1001/jama.2026.9487.
    PubMed        
    
    

    
    Kidney Int

63. XU Y, Maas CCHM, Huang T, Wang T, et al
    Heterogeneous Treatment Effects of GLP-1RA on Kidney Outcomes in Patients with Type 2 Diabetes.
    Kidney Int. 2026 Jul 24:S0085-2538(26)00612-5. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    
64. PAN Y, Harris RC
    The next step in liquid biopsies: urinary extracellular vesicle proteomics in kidney diseases and responses to treatment.
    Kidney Int. 2026;110:304-305.
    PubMed         Abstract available
    
    
65. ALPERS CE
    Renal biopsy in patients with diabetes: still going strong after all these years.
    Kidney Int. 2026;110:301-303.
    PubMed         Abstract available
    
    

    
    Metabolism

66. AI W, Pan Q, Shen Z, Yang W, et al
    Hepatic TGFbeta1 signaling impairs insulin sensitivity via inducing insulin receptor substrate 1 degradation.
    Metabolism. 2026;182:156654.
    PubMed         Abstract available
    
    
67. FAN Y, Chen X, Cai X, Dong Y, et al
    SGLT2 inhibitors and GLP-1 receptor agonists in atrial fibrillation treatment: Clinical evidence and mechanistic insights.
    Metabolism. 2026;182:156678.
    PubMed         Abstract available
    
    
68. DI GIUSEPPE G, Gliozzo G, Carciero L, Puzzangara MC, et al
    Differential mirroring between in vivo insulin secretion and ex vivo islet function in individuals with and without diabetes.
    Metabolism. 2026 Jul 24:156715. doi: 10.1016/j.metabol.2026.156715.
    PubMed         Abstract available
    
    
69. WU SD, Wang X, Zhou YM, Hu B, et al
    Setmelanotide alleviates diabetes-associated cognitive impairment by interrupting the binding of ICAM-1 and JIP1 in endothelial cells of the blood-brain barrier.
    Metabolism. 2026 Jul 24:156712. doi: 10.1016/j.metabol.2026.156712.
    PubMed         Abstract available
    
    

    
    Nature

70. TAMBETS R, Jesse M, Kronberg J, van der Graaf A, et al
    Genetic analysis of circulating metabolic traits in 619,372 individuals.
    Nature. 2026;655:971-978.
    PubMed         Abstract available
    
    

    
    Ophthalmology

71. DEPARIS SW, Oke I, Gaier ED, Moss HE, et al
    Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology.
    Ophthalmology. 2026 May 14:S0161-6420(26)00246.
    PubMed         Abstract available
    
    

    
    PLoS One

72. JAO WY, Lai CC, Chien CS, Lin WT, et al
    Comparative effects of SGLT2 inhibitors and GLP-1 receptor agonists on osteoarthritis risk in patients with type 2 diabetes mellitus: A multi-institutional cohort study.
    PLoS One. 2026;21:e0353956.
    PubMed         Abstract available
    
    
73. 
    Retraction: Application of IRSA-BP neural network in diagnosing diabetes.
    PLoS One. 2026;21:e0354316.
    PubMed        
    
    
74. HOSSAIN MS, Dwipi ST, Ahmed N, Murshed KM, et al
    Urinary podocalyxin as an early biomarker for diabetic nephropathy.
    PLoS One. 2026;21:e0347975.
    PubMed         Abstract available
    
    
75. SRAMEK J, Pierzynova A, Melenovsky V, Kucera T, et al
    Myocardial microvascular patterns in histological sections from patients with and without type 2 diabetes.
    PLoS One. 2026;21:e0354451.
    PubMed         Abstract available
    
    
76. ZHAO X, Tang C, Yuan T, Chen J, et al
    Lipid-modifying pharmacotherapy in diabetes mellitus: A protocol for a systematic review and network meta-analysis of randomised trials.
    PLoS One. 2026;21:e0354259.
    PubMed         Abstract available
    
    
77. HADJ-ABO A, Gusy B, Fleischhauer M
    Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study.
    PLoS One. 2026;21:e0353125.
    PubMed         Abstract available
    
    
78. ABERA EG, Himbaro SA, Megersa SW, Leta TA, et al
    Hidden deficiency under bright skies: Vitamin D prevalence and genetic associations in African Type 2 diabetes: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0354518.
    PubMed         Abstract available
    
    
79. IBRAHIM MS, Naqid IA
    Prevalence and associated risk factors of Pseudomonas aeruginosa infection in Diabetic wounds in Duhok province, Iraq.
    PLoS One. 2026;21:e0354256.
    PubMed         Abstract available
    
    

    
    Retina

80. HIROSAWA K, Inomata T, Nagino K, Sung J, et al
    Ultra-widefield color fundus images and artificial intelligence for diagnosis of diabetic retinopathy: A systematic review and meta-analysis.
    Retina. 2026 Jul 24. doi: 10.1097/IAE.0000000000004939.
    PubMed         Abstract available
    
    
81. ENGIN CD, Selver MA, Koksaldi S, Kayabasi M, et al
    GENERALIZABILITY OF DEEP LEARNING MODELS FOR REFERABLE DIABETIC RETINOPATHY DETECTION: A CROSS-POPULATION STUDY.
    Retina. 2026 Jul 21. doi: 10.1097/IAE.0000000000004924.
    PubMed         Abstract available
    
    
82. ZHAO J, Zhang Y, Miao Y, Shi W, et al
    Enhancing the performance of diabetic retinopathy grading models using synthetic images.
    Retina. 2026 Jul 21. doi: 10.1097/IAE.0000000000004919.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum